1. Perlin E, Oldham R, Weese J, Heim W, Reid J, Mills M, Miller C, Blom J, Green D, Bellinger S, Cannon G, Law I, Connor K, Herberman R: Immunotherapy of carcinoma of the lung by intradermal BCG and allogeneic tumor cells. J Radiat Oncol Biol Phys 6: 1033–1039, 1980
2. Dillman RO, Shawler DL, Johnson DE, Meyer DL, Koziol JA, Frincke JN: Preclinical trials with combinations and conjugates of T101 monoclonal antibody and doxorubicin. Cancer Res 46: 4886–4891, 1986
3. Harkonen S, Stoudemire J, Mischak R, Spitler LE, Lopez H, Scannon P: Toxicity and immunogenicity of monoclonal anti-melanoma antibody-ricin-A chain immunotoxin in rats. Cancer Res 47: 1377–1382, 1987
4. Maleckar JR, Friddell CS, Sferruzza A, Thurman GB, Lewko WM, West WH, Oldham RK, Yannelli JR: Activation and expansion of tumor derived activated cells (TDAC). J Natl Cancer Inst 1: 1655–1660, 1989
5. Reed MV, Gey GO: Cultivation of normal and malignant human lung tissue. Lab Invest 11: 638–652, 1962